Medical devices maker Tissue Regenix Group PLC (LON:TRX) has won an award at an industry conference over in the United States.
Group purchasing organisation Premier awarded Tissue the Supplier Horizon award, which recognises suppliers that have been contracted with Premier for less than three years for exceptional local customer service and engagement, value creation through clinical excellence and commitment to lower costs.
READ: Tissue Regenix Group inks new US deal, providing access to 3,900 hospitals
The awards are voted on by Premier’s members who have first-hand experience of using the products in a clinical setting.
It’s not the first time TRX has been recognised by Premier back in 2016 its dermal allograft, DermaPure, was presented with an Innovative Technology award.
“We are delighted to receive the Premier Horizon award,” said chief executive Steve Couldwell.
“It again highlights not only the differentiated clinical outcomes from the use of DermaPure, but also the health economic advantages of its' single application in many hospital settings.
“Being acknowledged by Premier's member institutions for such an award re affirms our value proposition in the space, and we look forward to continuing to establish these relationships.”